Notably, weight loss was accompanied by an increase in the abdominal circumference, which may indicate a systemic inflammatory response secondary to chemotherapy, possibly linked to hypercortisolism
Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases
Parsippany, NJ: Teva Pharmaceuticals USA, Inc
As the number of approved GLP-1 medications grows, clinicians will increasingly be able to choose from a menu of options, some of which may be especially appropriate for individual patients
they are partners in helping patients create habits that will keep the weight off long after the medication ends
"Endometriosis and infertility: pathophysiology, treatment strategies, and reproductive outcomes"